期刊文献+

常规MRI联合PWI对前列腺癌的诊断价值研究 被引量:2

The research of diagnosis value in prostatic carcinoma by using magnetic resonance imaging and perfusion-weighted imaging
在线阅读 下载PDF
导出
摘要 目的探讨良性前列腺增生(benign prostatichy perplasia,BPH)及前列腺癌(prostate carcinoma,PCa)磁共振成像(MRI)和磁共振灌注加权成像(PWI)表现以及灌注值,评价两者对BPH和PCa的诊断及鉴别诊断价值。方法对临床诊断为前列腺疾病的76例患者行常规MRI及PWI扫描,分析BPH及PCa的常规MRI表现及所获得时间-信号曲线(TIC),计算最大灌注斜率(SSmax)。结果 35例PCa及41例BPH的TIC均有明显的上升支,较之BPH组,PCa组TIC上升支较陡峭,峰值高,达峰时间短;PCa组的SSmax高于BPH组(P<0.05)。结论 MRI与PWI联合应用有助于PCa的诊断与鉴别诊断。 Objective To evaluate the value of MRI and PWI in diagnosing and differential diagnosing for benign and malignant prostate diseases.Methods MRI routine scanning and perfusion imaging were performed in consecutive 76 patients with clinically-proven prostatic disease.The signal time-intensity curve (TIC) and the maximum perfusion slope (SSmax) were obtained by Mean-Curve.Results In 35 patients with prostatic carcinoma and 26 patients with benign prostatic hyperplasia,the shapes of TIC in BPH group and PCa group are similar,both showing an obvious steep-up slope after the baseline.Compared with the BPH group,the upslope of TIC in PCa group is steeper,the peak is higher and the peak time is shorter.SSmax of prostatic carcinoma were higher than those of benign prostatic hyperplasia group (P0.01).Conclusions It is helpful to diagnosis and differential diagnosis of prostatic carcinoma when MRI and PWI are combined.
出处 《现代泌尿生殖肿瘤杂志》 2011年第5期264-268,共5页 Journal of Contemporary Urologic and Reproductive Oncology
关键词 前列腺肿瘤 前列腺增生 磁共振成像 灌注加权成像 Prostatic neoplasms Prostatic hyperplasia Magnetic resonance imaging Perfusion-weighted imaging
  • 相关文献

参考文献10

  • 1李鸣,张思维,马建辉,陈万青,那彦群.中国部分市县前列腺癌发病趋势比较研究[J].中华泌尿外科杂志,2009,30(6):368-370. 被引量:171
  • 2周作福,陈敏,王文超,蔡葵,钟晨阳,周诚,王建业,王占立,韦嘉瑚,李果珍.前列腺癌MRI诊断的探讨[J].实用放射学杂志,2000,16(4):198-200. 被引量:9
  • 3王锡臻,王滨,刘金刚,牛庆亮,张强.磁共振灌注成像与前列腺癌分期、分级及PSA的相关性研究[J].实用放射学杂志,2008,24(7):925-927. 被引量:10
  • 4王滨,L.W.TURNBULL.TURP手术对前列腺癌组织和非肿瘤组织血供影响的MRI评价[J].实用放射学杂志,2003,19(3):247-250. 被引量:5
  • 5Verstraete KL, Deene YD, Roels H, et al. Benign and ma lignant musculoskeletal lesions: dynamic contrast enhanced MR imaging parametric " first-pass" images depict tissue vascularization and perfusion [J]. Radiology, 19 9 4, 19 2 ( 3 ) : 835-843.
  • 6Sugahara T, Korogi Y, Kochi M, et al. Correlation of MR imaging-determined cerebral blood volume maps with histo logic and angiographie determination of vascularity of gliomas [J]. AJR, 1998,171 (6) : 1479-1486.
  • 7Petrella JR, Provenzale JM. MR perfusion imaging of the brain: techniques and applications [J]. AJR, 2000,175 ( 1 ) : 207-219.
  • 8Dugdale PE, Miles KA, Bunce I, et al. CT measurement of per{usion and permeability with in lymphoma masses and its ability to assess grade, activity and chemotherapeutic reponse [J]. J Comput Assist Tomogr,1999,23(4) :540-547.
  • 9Dhar M, Denstedt JD. Imaging in diagnosis,treatment, and follow-up of stone patients[J]. Adv Chronic Kidney Dis, 2009,16(1):39-47.
  • 10Pais VM, Payton AL, LaGrange CA. Urolithiasis in Pregnancy[J]. UrolClinNorthAm,2007,34(1):43-52.

二级参考文献26

  • 1张继斌,沈钧康,许建铭,李晓兵,须同禄,陆之安,秦明明.前列腺癌MR灌注成像与肿瘤血管生成相关性研究[J].临床放射学杂志,2004,23(6):485-488. 被引量:14
  • 2张思维,陈万青,孔灵芝,李连弟,鲁凤珠,李光琳,孟佳,赵平.中国部分市县1998~2002年恶性肿瘤的发病与死亡[J].中国肿瘤,2006,15(7):430-448. 被引量:171
  • 3Folkman J, Shing Y. Angiogenesis (Review) [J]. J Biol Chem, 1992, 267(16) : 10931 - 10934.
  • 4Dvorak AM, Feng D. The vesiculo - vacuolar organelle (VVO) : A new endothelial cell permeability organelle [ J ]. J Histochem Cytochem, 2001, 49(4) : 419 -432.
  • 5Strohmeyer D, Strauss F, Rossing C, et al. Expression of bFGF, VEGF and c - met and their correlation with microvessel density and progression in prostate carcinoma [ J ]. Anticancer Res, 2004, 24 (3a) :1797 - 1804.
  • 6Strohmeyer D, Rossing C, Bauerfeind A, et al. Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer [ J ]. Prostate. 2000, 45 ( 3 ) : 216 - 224.
  • 7Wang B, Lowry M, Turnbull L. Dynamic contrast - enhanced MR imaging of the prostate: correlation with tumor stage, histological grade and PSA[ C]. Proc Intl Mag Reson Med, 2001, 9:2413.
  • 8Kikuno N, Yoshino T, Urakami S, et al. The role of thymidine phosphorylase (TP) mRNA expression in angiogenesis of prostate cancer[ J ]. Anticancer Res, 2003, 23 ( 2B ) : 1305 - 1312.
  • 9李连弟,饶克勤.中国试点市县恶性肿瘤的发病与死亡第1卷(1988-1992).北京:中国医药科技出版社,2002:263-289.
  • 10李连弟,饶克勤.中国试点市县恶性肿瘤的发病与死亡第2卷(1993-1997).北京:中国医药科技出版社,2003:269-295.

共引文献189

同被引文献64

  • 1王霄英,周良平,丁建平,李飞宇,山刚志,肖江喜,蒋学祥.RS对中国人前列腺癌鉴别诊断标准的初步研究[J].中国医学影像技术,2004,20(8):1150-1153. 被引量:98
  • 2钱均琪,张绍渤,黄受方.前列腺癌的病理学进展[J].中华病理学杂志,1996,25(4):253-255. 被引量:20
  • 3Nix JW,Turkbey B,Hoang A. Very distal apical prostate tumours:identification on multiparametric MRI at 3 Tesla[J].{H}BJU International,2012,(11 Pt B):E694-E700.
  • 4Tüirkbey B,Bernardo M,Merino M J. MRI of localized prostate cancer:coming of age in the PSA era[J].Diagn Interv Radiol,2012,(1):34-45.
  • 5Soylu FN,Eggener S,Oto A. Local staging of prostate cancer with M RI[J].Diagn Interv Radiol,2012,(4):365-373.
  • 6Franiel T,Hamm B,Hricak H. Dynamic contrast-enhanced magnetic resonance imaging and pharmacokinetic models in prostate cancer[J].{H}European Radiology,2011,(3):616-626.
  • 7Chen YJ,Chu WC,Pu YS. Washout gradient in dynamic contrast-enhanced MRI is associated with tumor aggressiveness of prostate cancer[J].{H}Journal of Magnetic Resonance Imaging,2012,(4):912-919.
  • 8Kurhanewicz J,Vigneron DB,Hricak H. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high(0.24-0.70-cm3) spatial resolution[J].{H}RADIOLOGY,1996,(3):795-805.
  • 9Scheidler J,Hricak H,Vigneron DB. Prostate cancer:localization with three-dimensional proton MR spectroscopic imagingclinicopathologic study[J].{H}RADIOLOGY,1999,(2):473-480.
  • 10Zakian KL,Sircar K,Hricak H. Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy[J].{H}RADIOLOGY,2005,(3):804-814.

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部